Servier

Focus: Servier is a 10,000+ employee private pharmaceutical company headquartered in France with a diversified pipeline spanning oncology, CNS, cardiovascular, and rare diseases. As a mid-sized private pharma, it operates independently with significant R&D investment capacity.

Profile data last refreshed 2h ago · AI intelligence enriched 2w ago

Funding Stage

PRIVATE

Employees

10001+

Open Jobs

About Servier

AI assessmentNot Hiring

No open roles listed right now. Follow Servier to get notified when they start hiring — the background below is worth knowing for when they do.

Why Work Here

Data completeness

1/9 — Limited

Company HealthSolid

Pipeline

Early-stage

50 total

LOE Risk

Protected

No near-term cliffs

Hiring

0 open

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Pipeline & Clinical Trials

Molecular Reclassification to Find Clinically Useful Biomarkers for Systemic Autoimmune Diseases: Ca

Healthy Subjects

N/A

aCute HemORrhoidal Disease evALuation International Study

Hemorrhoids

N/A

Clinical Trials (1)

Help build intelligence for Servier

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Diverse pipeline with 20 active programs spanning Phase 1-3, including potentially high-impact assets in glioma (Vorasidenib Phase 3), MDS (Ivosidenib Phase 3), and rare disease (Gevokizumab Phase 3 for Behçet's Uveitis)
Private ownership structure provides strategic independence and potential for long-term R&D investment without quarterly earnings pressure
European headquarters offers career mobility across global operations with strong French pharma heritage

Watch Out For

No active job postings reported, suggesting limited near-term hiring and potential recruitment freeze or outsourcing model
Limited public financial data and patent cliff visibility prevents assessment of long-term stability and restructuring risk
Pipeline skews early-stage (6 Phase 1, 9 Phase 2, 0 Phase 3 reported in trial summary) with limited near-term commercial catalysts

Generated by Claude from Servier's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.

NCT04578730aCute HemORrhoidal Disease evALuation International Study

N/A

Real-world Clinical Effectiveness and Patient Insight Associated With Adding Sodium Glucose Co-trans

Type 2 Diabetes

N/A

Clinical Trials (1)

NCT06708091Real-world Clinical Effectiveness and Patient Insight Associated With Adding Sodium Glucose Co-transporter 2 Inhibitor to Gliclazide Modified Release

N/A

Chronic VEnous dIsorders maNagement and Treatment effectivenesS evaluaTion in Chronic vEnous Disease

Chronic Venous Disease

N/A

Clinical Trials (1)

NCT04574375Chronic VEnous dIsorders maNagement and Treatment effectivenesS evaluaTion in Chronic vEnous Disease, an International Program

N/A

Hemorrhoid Disease Questionnaire

Haemorrhoids

N/A

Clinical Trials (1)

NCT04943666The Russian Multicenter Observational Study "Evaluation of the HDQ for the Diagnosis of Hemorrhoidal Disease ( HDQ )

N/A

in daily everyday routine practice

Chronic Venous Insufficiency

N/A

Clinical Trials (1)

NCT04757766VAP-PRO-C6. Effectiveness and Tolerability of Venoactive Drugs in Combination Therapy in Patients With CVD (CEAP C6)

N/A

Action in Diabetes and Vascular Disease Preterax and Diamicron MR Controlled Evaluation Post Trial O

Diabetes Mellitus, Type 2

N/A

Clinical Trials (1)

NCT00949286Action in Diabetes and Vascular Disease Preterax and Diamicron MR Controlled Evaluation Post Trial Observational Study

N/A

Observational Cohort Study Evaluating the Effectiveness of an Education Program (NGAYDAUTIEN) in Com

Type 2 Diabetes

N/A

Clinical Trials (1)

NCT06704802Observational Cohort Study Evaluating the Effectiveness of an Education Program (NGAYDAUTIEN) in Combination With Gliclazide MR in the Management of Uncontrolled Type 2 Diabetic Patients.

N/A

Real World Efficacy, Safety of Nanoliposomal Irinotecan With Fluorouracil and Folinic Acid in Metast

Pancreatic Adenocarcinoma Metastatic

N/A

Clinical Trials (1)

NCT06006728Real World Efficacy, Safety of Nanoliposomal Irinotecan With Fluorouracil and Folinic Acid in Metastatic Pancreatic Cancer After Previous Gemcitabine-based Therapy

N/A

Hemorrhoidectomy, Thrombectomy , Operation on Longo method

Hemorrhoids

N/A

Clinical Trials (1)

NCT03743311Data on the Impact of Different Treatment on the Quality of Life of Patients With Acute and Chronic Hemorrhoid Disease

N/A

Observational registry with no intervention.

ACS

N/A

Clinical Trials (1)

NCT05857735Kuwait Heart Foundation Registry of Acute Coronary Events

N/A

echocardiography, computed tomography

Cardiotoxicity

N/A

Clinical Trials (1)

NCT05118178Atherosclerosis in Chemotherapy-related Cardiotoxicity

N/A

Diagnostic and Prognostic Value of New Biomarkers in Patients With Heart Disease

Heart Failure

N/A

Clinical Trials (1)

NCT01374880Diagnostic and Prognostic Value of New Biomarkers in Patients With Heart Disease

N/A

Retrospective Medical Record Review

Acute Lymphoblastic Leukemia

N/A

Clinical Trials (1)

NCT07246213CAYA Cancer Retrospective Cohort Study

N/A

Ivosidenib in Locally Advanced or Metastatic Cholangiocarcinoma With IDH1 R132 Mutation After at Lea

Cholangiocarcinoma

N/A

Clinical Trials (1)

NCT06607302Ivosidenib in Locally Advanced or Metastatic Cholangiocarcinoma With IDH1 R132 Mutation After at Least One Prior Systemic Treatment - an Observational Study

N/A

Improving Goal Directed Medical Therapy for Device Clinic Patients With Reduced EF at UOHI: a QI Ini

Heart Failure

N/A

Effectiveness and Tolerability of аgomelatine in the Treatment of Patients With Depression After SAR

Depression

N/A

Clinical Trials (1)

NCT05323994Effectiveness and Tolerability of аgomelatine in the Treatment of Patients With Depression After SARS-CoV-2 (TELESPHOR)

N/A

Trifluridine/Tipiracil

Metastatic Colorectal Cancer

N/A

Clinical Trials (1)

NCT04965870A Study of Trifluridine/ Tipiracil in Chemorefractory mCRC in Greece

N/A

Electronic patient decision aid

Atrial Fibrillation

N/A

Clinical Trials (1)

NCT05900414RAPID AFib Decision Aid for Stroke Prevention in Atrial Fibrillation

N/A

Amlodipine 5 mg + atorvastatin 10 mg + perindopril arginine 5 mg

Arterial Hypertension

N/A

Clinical Trials (1)

NCT05764317Description of the Effectiveness, Safety, Tolerability and Adherence to Amlodipine/Atorvastatin/Perindopril Single Pill Combination Treatment in Patients With Arterial Hypertension and Dyslipidemia (TARGET)

N/A

in daily everyday routine practice

Coronary Artery Disease

N/A

Clinical Trials (1)

NCT04656847PRIDE. Assessment of the Efficacy, Adherence and Tolerability of the Single Pill Combination Bisoprolol/Perindopril

N/A

RWE on Patients With mPDAC Long-term Survival After Treatment With Liposomal Irinotecan

Pancreatic Cancer Metastatic

N/A

Clinical Trials (1)

NCT06155136RWE on Patients With mPDAC Long-term Survival After Treatment With Liposomal Irinotecan

N/A

ONIVYDE

Metastatic Pancreatic Cancer

N/A

Clinical Trials (1)

NCT03446872Post Marketing Surveillance Study for ONIVYDE® in South Korea

N/A

Perindopril/Indapamide/Amlodipine fixed dose combination

Adherence to Medication Regime

N/A

Clinical Trials (1)

NCT02655029Study for the Recording of Adherence to Treatment With Perindopril/Indapamide/Amlodipine Fixed Dose Combination

N/A

Extensive phenotyping

Heart Failure

N/A

Clinical Trials (1)

NCT04189029PACIFIC-PRESERVED : PhenomApping, ClassIFication, and Innovation for Cardiac Dysfunction - HF With PRESERVED LVEF Study

N/A

Impact of Heart Failure on Calcium Homeostasis and Mitochondrial Function in Human Skeletal Muscle

Heart Failure

N/A

Clinical Trials (1)

NCT01014611Impact of Heart Failure on Calcium Homeostasis and Mitochondrial Function in Human Skeletal Muscle

N/A

Amlodipine 5 mg + indapamide 1.25 mg + perindopril 5 mg

Arterial Hypertension

N/A

Clinical Trials (1)

NCT06259175Evaluation of the Antihypertensive effectIveness, Tolerability, and Adherence With Amlodipine/ Indapamide/ Perindopril Triple Single-pill Combination in Hypertensive Patients Without Concomitant Antihypertensive Therapy (TRIPTYCH)

N/A

A 2-year, European Multicentre Study to Describe, Validate, and Predict Phenotypes of Knee Osteoarth

Knee Osteoarthritis

N/A

Clinical Trials (1)

NCT03883568A 2-year, European Multicentre Study to Describe, Validate, and Predict Phenotypes of Knee Osteoarthritis

N/A

POLUS: Description of the Effectiveness and Tolerability of Luseogliflozin in Patients With Type 2 D

Type 2 Diabetes Mellitus

N/A

Clinical Trials (1)

NCT07433192POLUS: Description of the Effectiveness and Tolerability of Luseogliflozin in Patients With Type 2 Diabetes.

N/A

speckle tracking mode of the stress ECHO test with dobutamine

Coronary Artery Disease

N/A

Clinical Trials (1)

NCT05210465Objective Confirmation of thе Anti-ischemic Effectiveness of Trimetazidine 80mg Once Daily in Patients With Stable Angina Who Had a History of Myocardial Infarction (METHOD)

N/A

Exercise training,

Heart Failure

N/A

Clinical Trials (1)

NCT01956721Impact of Heart Failure on Calcium Homeostasis and Mitochondrial Function in Human Skeletal Muscle

N/A

observational disease study

Metastatic Colorectal Cancer

N/A

Clinical Trials (1)

NCT03935763Management of Metastatic Colorectal Cancer: A Clinical and Patient Perspective

N/A

Edoxaban Pill

Atrial Fibrillation and Flutter

N/A

Clinical Trials (1)

NCT03488420Canadian EdoxAban(Lixiana®) Registry in Patients With ATrial Fibrillation/Flutter With Confirmed ValvUlar HeaRt DiseasE

N/A

Gulf Acute Heart Failure Registry

Acute Heart Failure

N/A

Clinical Trials (1)

NCT01467973Gulf Acute Heart Failure Registry

N/A

Vorasidenib

Gliomas

N/A

Clinical Trials (1)

NCT06969352A Multicentre, Retrospective-prospective Real-world Study: to Evaluate the Effectiveness and Safety of Vorasidenib in Patients With Isocitrate Dehydrogenase IDH1/2 Mutant Grade 2 Astrocytoma or Oligodendroglioma (VICTORIA Study)

N/A

Diabeton 60 MR

Type2 Diabetes

N/A

Clinical Trials (1)

NCT03164187Evaluation of Type 2 Diabetes Treatment

N/A

bisoprolol/perindopril FDC

Arterial Hypertension

N/A

Clinical Trials (1)

NCT03730116Assessment of the Efficacy and Tolerability of the Fixed-dose Combination of Bisoprolol/Perindopril

N/A

amlodipine / indapamide / perindopril arginine FDC

Arterial Hypertension

N/A

Clinical Trials (1)

NCT03722524The Use of TrIple Fixed-dose Combination in the Treatment of Arterial Hypertension

N/A

Echo stress dipyridamole

Hypertension,Essential

N/A

Clinical Trials (1)

NCT03841383Association Between Coronary Flow Reserve and BH4 Levels in High CV Risk

N/A

Wearing Cardioskin™ for 14 days

Atrial Fibrillation

N/A

Clinical Trials (1)

NCT03964025Clinical Investigation to Determine the Accuracy and Benefit of Cardioskin™ in Patients With Known Atrial Fibrillation

N/A

Control group

Osteoporosis

N/A

Vorasidenib

Glioma

N/A

Clinical Trials (1)

NCT05592743Vorasidenib Expanded Access Program

N/A

Triple Fixed-Dose Combination

Apparent Resistant Hypertension

N/A

Clinical Trials (1)

NCT07259733Rapid Management of Resistant Hypertension in the Public Health System (Fast Control)

N/A

Effectiveness of a Combination of Trimetazidine With One Hemodynamic Agent in Patients Recently Diag

Stable Angina

N/A

Clinical Trials (1)

NCT06298045Effectiveness of a Combination of Trimetazidine With One Hemodynamic Agent in Patients Recently Diagnosed With Stable Angina and Still Symptomatic Despite First Line Hemodynamic Therapy

N/A

Trifluridin/Tipiracil

Metastatic Colorectal Cancer

N/A

Clinical Trials (1)

NCT03665506Trifluridin/tipirACil in MeTastatIc Colorectal Cancer

N/A

Observational Study of Effectiveness and Tolerability of Gliclazide MR 60mg in Diabetic Patients Fas

Type 2 Diabetes

N/A

Clinical Trials (1)

NCT04132934Observational Study of Effectiveness and Tolerability of Gliclazide MR 60mg in Diabetic Patients Fasting During RAMADAN

N/A

The Angiotensin Converting Enzyme (ACE) Inhibitor SwitchBack Study

Heart Failure

N/A

Clinical Trials (1)

NCT01162980The Angiotensin Converting Enzyme (ACE) Inhibitor SwitchBack Study

N/A

Observational Cohort Study Evaluating the Effectiveness of an Educational Program (NGAYDAUTIEN) in C

Hypertension

N/A

Clinical Trials (1)

NCT06704815Observational Cohort Study Evaluating the Effectiveness of an Educational Program (NGAYDAUTIEN) in Combination With Perindopril and Amlodipine Single-Pill Combination in Hypertensive Patients naïve of Antihypertensive Treatments.

N/A

Prednisone

Acute Lymphoid Leukemia

N/A

Clinical Trials (1)

NCT05959720Adult Acute Lymphoblastic Leukemia Treated With Pediatric Regimen in Brazil

N/A

MRI Scan

Low Grade Glioma of Brain

N/A

Clinical Trials (1)

NCT06648473Repeatability of Magnetic Resonance Imaging in Patients With IDH1 Mutant Glioma on Ivosidenib